Telemedicine Abortion

被引：5
作者：
Dunlop, Hayley [1 ]
Sinay, Anne-Marie [2 ]
Kerestes, Courtney [2 ,3 ]
机构：
[1] Ohio State Univ, Coll Med, Columbus, OH USA
[2] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH USA
[3] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA
来源：
CLINICAL OBSTETRICS AND GYNECOLOGY | 2023年 / 66卷 / 04期
关键词：
telemedicine; abortion; medication abortion; no-test abortion; access to care; TO-PATIENT TELEMEDICINE; MEDICAL ABORTION; FOLLOW-UP; MIFEPRISTONE; SERVICE; MISOPROSTOL; EXPERIENCE; PREGNANCY; ACCEPTABILITY; ULTRASOUND;
D O I：
10.1097/GRF.0000000000000818
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Telemedicine has become a substantial part of abortion care in recent years. In this review, we discuss the history and regulatory landscape of telemedicine for medication abortion in the United States, different models of care for telemedicine, and the safety and effectiveness of medication abortion via telemedicine, including using history-based screening protocols for medication abortion without ultrasound. We also explore the acceptability of telemedicine for patients and their perspectives on its benefits, as well as the use of telemedicine for other parts of abortion care. Telemedicine has expanded access to abortion for many, although there remain limitations to its implementation.
引用
收藏
页码：725 / 738
页数：14
相关论文
共 50 条
[21]   Medical abortion provided by telemedicine to women in Latin America: complications and their treatment [J].
Larrea, Sara ;
Palencia, Laia ;
Perez, Gloria .
GACETA SANITARIA, 2015, 29 (03) :198-204
[22]   Clinical and service delivery implications of omitting ultrasound b efore me dication abortion provide d via direct-to-patient telemedicine and mail in the U.S [J].
Anger, Holly A. ;
Raymond, Elizabeth G. ;
Grant, Melissa ;
Haskell, Sue ;
Boraas, Christy ;
Tocce, Kristina ;
Banks, Joey ;
Coplon, Leah ;
Shochet, Tara ;
Platais, Ingrida ;
Winikoff, Beverly .
CONTRACEPTION, 2021, 104 (06) :659-665
[23]   Telemedicine for First-Trimester Medical Abortion in Canada: Results of a 2019 Survey [J].
Renner, Regina M. M. ;
Ennis, Madeleine ;
Kyeremeh, Ama ;
Norman, Wendy V. V. ;
Dunn, Sheila ;
Pymar, Helen ;
Guilbert, Edith .
TELEMEDICINE AND E-HEALTH, 2023, 29 (05) :686-695
[24]   Early medical abortion [J].
Cameron, Sharon T. .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2025, 99
[25]   Telemedicine for the provision of medication abortion to pregnant people at up to twelve weeks of pregnancy: a systematic literature review and meta-analysis [J].
Cely-Andrade, Leonardo ;
Cardenas-Garzon, Karen ;
Enriquez-Santander, Luis Carlos ;
Saavedra-Avendano, Biani ;
Avendano, Guillermo Antonio Ortiz .
REPRODUCTIVE HEALTH, 2024, 21 (01)
[26]   Early serum human chorionic gonadotropin (hCG) trends after medication abortion [J].
Pocius, Katherine D. ;
Maurer, Rie ;
Fortin, Jennifer ;
Goldberg, Alisa B. ;
Bartz, Deborah .
CONTRACEPTION, 2015, 91 (06) :503-506
[27]   Introduction of telemedicine for medication abortion: Changes in service delivery patterns in two US states [J].
Kohn, Julia E. ;
Snow, Jennifer L. ;
Grossman, Daniel ;
Thompson, Terri-Ann ;
Seymour, Jane W. ;
Simons, Hannah R. .
CONTRACEPTION, 2021, 103 (03) :151-156
[28]   A telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial [J].
Endler, Margit ;
Petro, Gregory ;
Danielsson, Kristina Gemzell ;
Grossman, Dan ;
Gomperts, Rebecca ;
Weinryb, Maja ;
Constant, Deborah .
LANCET, 2022, 400 (10353) :670-679
[29]   The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States [J].
Mark, Alice ;
Foster, Angel M. ;
Perritt, Jamila .
CONTRACEPTION, 2021, 104 (01) :38-42
[30]   Evaluation of telemedicine medical abortion using a no-test protocol in the Eastern Europe and Central Asian region: Evidence from Ukraine, Uzbekistan, and Azerbaijan [J].
Tsereteli, Tamar ;
Platais, Ingrida ;
Maru, Mahlet ;
Maystruk, Galyna ;
Kurbanbekova, Dilfuza ;
Rzayeva, Gulnara ;
Winikoff, Beverly .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 167 (02) :804-809
12345